BEAM
Price
$21.66
Change
-$0.21 (-0.96%)
Updated
Nov 13, 04:59 PM (EDT)
Capitalization
2.2B
109 days until earnings call
Intraday BUY SELL Signals
PYXS
Price
$4.48
Change
+$0.11 (+2.52%)
Updated
Nov 13 closing price
Capitalization
278.94M
131 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

BEAM vs PYXS

Header iconBEAM vs PYXS Comparison
Open Charts BEAM vs PYXSBanner chart's image
Beam Therapeutics
Price$21.66
Change-$0.21 (-0.96%)
Volume$108.35K
Capitalization2.2B
Pyxis Oncology
Price$4.48
Change+$0.11 (+2.52%)
Volume$595.8K
Capitalization278.94M
BEAM vs PYXS Comparison Chart in %
View a ticker or compare two or three
VS
BEAM vs. PYXS commentary
Nov 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BEAM is a Hold and PYXS is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 14, 2025
Stock price -- (BEAM: $21.87 vs. PYXS: $4.37)
Brand notoriety: BEAM and PYXS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BEAM: 71% vs. PYXS: 111%
Market capitalization -- BEAM: $2.2B vs. PYXS: $278.94M
BEAM [@Biotechnology] is valued at $2.2B. PYXS’s [@Biotechnology] market capitalization is $278.94M. The market cap for tickers in the [@Biotechnology] industry ranges from $110.25B to $0. The average market capitalization across the [@Biotechnology] industry is $2.1B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BEAM’s FA Score shows that 1 FA rating(s) are green whilePYXS’s FA Score has 0 green FA rating(s).

  • BEAM’s FA Score: 1 green, 4 red.
  • PYXS’s FA Score: 0 green, 5 red.
According to our system of comparison, PYXS is a better buy in the long-term than BEAM.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BEAM’s TA Score shows that 4 TA indicator(s) are bullish while PYXS’s TA Score has 4 bullish TA indicator(s).

  • BEAM’s TA Score: 4 bullish, 7 bearish.
  • PYXS’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, PYXS is a better buy in the short-term than BEAM.

Price Growth

BEAM (@Biotechnology) experienced а -5.20% price change this week, while PYXS (@Biotechnology) price change was +11.76% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.51%. For the same industry, the average monthly price growth was -3.12%, and the average quarterly price growth was +61.90%.

Reported Earning Dates

BEAM is expected to report earnings on Mar 03, 2026.

PYXS is expected to report earnings on Mar 25, 2026.

Industries' Descriptions

@Biotechnology (+1.51% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BEAM($2.2B) has a higher market cap than PYXS($279M). PYXS YTD gains are higher at: 180.128 vs. BEAM (-11.815). PYXS has higher annual earnings (EBITDA): -83.16M vs. BEAM (-414.33M). BEAM has more cash in the bank: 1.15B vs. PYXS (88.9M). PYXS has less debt than BEAM: PYXS (19.5M) vs BEAM (155M). BEAM has higher revenues than PYXS: BEAM (60.3M) vs PYXS (2.82M).
BEAMPYXSBEAM / PYXS
Capitalization2.2B279M788%
EBITDA-414.33M-83.16M498%
Gain YTD-11.815180.128-7%
P/E RatioN/AN/A-
Revenue60.3M2.82M2,138%
Total Cash1.15B88.9M1,294%
Total Debt155M19.5M795%
TECHNICAL ANALYSIS
Technical Analysis
BEAMPYXS
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
77%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
80%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
80%
MACD
ODDS (%)
Bearish Trend 2 days ago
85%
Bullish Trend 2 days ago
83%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
83%
Bullish Trend 2 days ago
83%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
83%
Bullish Trend 2 days ago
89%
Advances
ODDS (%)
Bullish Trend 8 days ago
78%
Bullish Trend 8 days ago
83%
Declines
ODDS (%)
Bearish Trend 4 days ago
84%
Bearish Trend 2 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
89%
Aroon
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
BEAM
Daily Signal:
Gain/Loss:
PYXS
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CHBAF10.80N/A
N/A
Chiba Bank, Ltd. (The)
DPNEF0.04N/A
N/A
Daphne International Holdings Ltd.
CLYYF0.20N/A
N/A
Celyad Oncology SA
FRBP10.00N/A
N/A
FRANKLIN BSP CAPITAL CORP
SHECF29.70-0.08
-0.28%
Shin-Etsu Chemical Co., Ltd.

BEAM and

Correlation & Price change

A.I.dvisor indicates that over the last year, BEAM has been closely correlated with CRSP. These tickers have moved in lockstep 69% of the time. This A.I.-generated data suggests there is a high statistical probability that if BEAM jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BEAM
1D Price
Change %
BEAM100%
-2.71%
CRSP - BEAM
69%
Closely correlated
-5.47%
RXRX - BEAM
62%
Loosely correlated
-1.27%
NTLA - BEAM
61%
Loosely correlated
-6.78%
PRME - BEAM
61%
Loosely correlated
-9.44%
AXON - BEAM
57%
Loosely correlated
-0.47%
More

PYXS and

Correlation & Price change

A.I.dvisor indicates that over the last year, PYXS has been loosely correlated with KURA. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if PYXS jumps, then KURA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PYXS
1D Price
Change %
PYXS100%
-4.38%
KURA - PYXS
59%
Loosely correlated
-0.09%
ZBIO - PYXS
42%
Loosely correlated
+1.70%
BEAM - PYXS
42%
Loosely correlated
-2.71%
CABA - PYXS
39%
Loosely correlated
-0.81%
SYRE - PYXS
38%
Loosely correlated
+0.34%
More